We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...
This latest collab between Casio and the Charles Darwin Foundation are the perfect wrist candy for animal lovers.
Galapagos will gain full development and commercialization rights to its pipeline, and is subject to single digit royalty ...
After the separation, Gilead will hold around 25% of the outstanding shares in both Galapagos and the spin-off company. While ...
Belgian biotech company Galapagos NV plans to spin off part of its operations, creating a new listed firm with approximately ...
Leerink Partners analyst Faisal Khurshid has maintained their neutral stance on GLPG stock, giving a Hold rating on December 23.Stay Ahead of ...
Galapagos NV plans to split into two entities by mid-2025, focusing on oncology cell therapy and innovative medicines, with ...
U.S.-listed shares rose over 4% in Wednesday's premarket after it announced a significant restructuring plan, including a ...
Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines ...